about
The GB viruses: a review and proposed classification of GBV-A, GBV-C (HGV), and GBV-D in genus Pegivirus within the family FlaviviridaeHTLV-1/-2 and HIV-1 co-infections: retroviral interference on host immune statusAn 85-aa segment of the GB virus type C NS5A phosphoprotein inhibits HIV-1 replication in CD4+ Jurkat T cellsCharacterization of an Immunodominant Antigenic Site on GB Virus C Glycoprotein E2 That Is Involved in Cell BindingCharacterization of a Peptide Domain within the GB Virus C NS5A Phosphoprotein that Inhibits HIV ReplicationGBV-C viremia is associated with reduced CD4 expansion in HIV-infected people receiving HAART and interleukin-2 therapyHIV-1 fusion is blocked through binding of GB Virus C E2-derived peptides to the HIV-1 gp41 disulfide loop [corrected]Human pegivirus RNA is found in multiple blood mononuclear cells in vivo and serum-derived viral RNA-containing particles are infectious in vitroPrevalence, incidence density, and genotype distribution of GB virus C infection in a cohort of recently HIV-1-infected subjects in Sao Paulo, BrazilThe GB virus C (GBV-C) NS3 serine protease inhibits HIV-1 replication in a CD4+ T lymphocyte cell line without decreasing HIV receptor expressionGBV-C infection and risk of NHL among U.S. adults.Identification of hepatotropic viruses from plasma using deep sequencing: a next generation diagnostic toolEvaluation of prevalence and risk factors of hepatitis g virus infection among hemodialysis patients referred to Iranian army hospitals in tehran during 2012-2013.GB virus C coinfections in west African Ebola patients.GB virus C coinfection in advanced HIV type-1 disease is associated with low CCR5 and CXCR4 surface expression on CD4(+) T-cells.Downregulation of Cytokines and Chemokines by GB Virus C After Transmission Via Blood Transfusion in HIV-Positive Blood RecipientsTransmission of GB virus type C via transfusion in a cohort of HIV-infected patients.GB virus C infection and B-cell, natural killer cell, and monocyte activation markers in HIV-infected individuals.Durable sequence stability and bone marrow tropism in a macaque model of human pegivirus infectionGB virus C envelope protein E2 inhibits TCR-induced IL-2 production and alters IL-2-signaling pathwaysGB virus C viremia is associated with higher levels of double-negative T cells and lower T-cell activation in HIV-infected individuals receiving antiretroviral therapy.GB virus C: the good boy virus?GB virus type C interactions with HIV: the role of envelope glycoproteins.GB virus type C envelope protein E2 elicits antibodies that react with a cellular antigen on HIV-1 particles and neutralize diverse HIV-1 isolatesViruses within the Flaviviridae decrease CD4 expression and inhibit HIV replication in human CD4+ cells.Characterization of a peptide domain within the GB virus C envelope glycoprotein (E2) that inhibits HIV replication.Acquisition of GB virus type C and lower mortality in patients with advanced HIV disease.GB virus C infection is associated with a reduced rate of reactivation of latent HIV and protection against activation-induced T-cell deathDeep sequencing identifies two genotypes and high viral genetic diversity of human pegivirus (GB virus C) in rural Ugandan patients.GB virus C particles inhibit T cell activation via envelope E2 protein-mediated inhibition of TCR signaling.Current Views on the Pathophysiology of GB Virus C Coinfection with HIV-1 Infection.Potential utility of GB virus type C as a preventive vaccine for HIV-1.Role of GB virus C in modulating HIV diseaseTropism of human pegivirus (formerly known as GB virus C/hepatitis G virus) and host immunomodulation: insights into a highly successful viral infection.Detection of GB virus C genomic sequence in the cerebrospinal fluid of a HIV-infected patient in China: a case report and literature review.Prevalence and vertical transmission of human pegivirus among pregnant women infected with HIV.Human Pegivirus (HPgV; formerly known as GBV-C) inhibits IL-12 dependent natural killer cell function.Chimpanzee GB virus C and GB virus A E2 envelope glycoproteins contain a peptide motif that inhibits human immunodeficiency virus type 1 replication in human CD4⁺ T-cells.Synthetic peptides derived from an N-terminal domain of the E2 protein of GB virus C in the study of GBV-C/HIV-1 co-infection.Prevalence and genotypes of GBV-C and its associations with HIV infection among persons who inject drugs in Eastern Europe.
P2860
Q24609524-9BDCF6C7-DF6B-438B-BD9F-1B31998FBF3AQ26866444-45580D74-C4D6-4B1E-9A63-62A1F0C54942Q27477568-049665F6-B090-42E6-8955-B22D08F5E958Q27477720-F11BA3CC-AA75-48CA-B5E7-D0B2B913AED3Q27486387-AEE827DD-23AA-48D7-8D69-88D0F23EC7A8Q27489561-018DD0F3-7757-4EFE-B547-46E672646906Q28485218-B486607D-0699-4B6C-9820-222A6D93FF0CQ33635101-5E835189-DE75-46FD-8F49-7A1C7F5F56BFQ33869199-12E6F27D-350C-4CB8-AD56-6176F5A55864Q34146275-9456E57B-3C89-402A-8410-717FBB6BCF9BQ34287698-B5E64340-F45B-4163-952D-E66D67F1B833Q34683707-E69866AD-EBD2-4F37-BEDA-CB1E5465F529Q35089905-A244B999-1B83-44C9-A658-9375C10675C3Q35115707-68B19A8D-992A-4419-A63B-D7E88744DE50Q35534529-D6B5D775-7CC1-4273-8E19-63C320DD1B18Q35784618-1872CF0C-6241-470D-8D85-BDD4DA3A6BEDQ35883423-EE406160-B7D9-4F47-9BC8-CB72BDB35B81Q35962494-257B35DD-1C4C-4508-A467-50EAA0834A33Q36160933-A69A5ED6-2641-45AE-B0C3-785912E94754Q36179796-00BAA977-24B2-4D8F-B2A8-D95642A9BF17Q36305449-F27418DA-B7F3-421F-B1DC-188F02437473Q36336499-B92DC436-F211-4B56-8C5D-867CB2AF20EBQ36528539-D6E3C315-CFB4-421C-8483-EDE2841B70F9Q36530370-77C5892C-54B0-4B25-AC4A-4366571B5674Q36570711-8C7DCEC2-1F55-46AF-9664-3C282CDA27E0Q36598453-101C11F3-7EA0-40C3-B8FB-0213BCF537FEQ36854006-7E64A6E1-58B5-467D-B20C-4FFB12D50771Q37007606-AE25CA6B-E01A-4DC2-918E-D37BE2A43E2AQ37332277-C4C3F0AB-BFA6-451E-A9CB-6AB8FFE49C7BQ37662365-82E55A3C-4098-4820-A2F4-5F08BAD44D5DQ37838793-12D5B1AF-B86D-4938-A2B3-DA040917E814Q37989574-F0DD7A9E-2D12-4A44-87B0-31E386E508E0Q38018981-334AFD83-F46E-48F1-903C-5AD0DC2540EDQ38350416-8B4235E0-3183-48F0-9DD4-F3577789EDE4Q38529649-53579A9B-267D-425C-BACF-EEC6C3518A0CQ38845889-8EB09D6E-4DBC-40D5-AFA6-B024644EDABBQ38846135-0374E502-A470-4D4F-96B9-13B545B85788Q39216631-09CF6CE6-E36D-4A9F-B84B-EFD17B65164CQ39375757-D1634054-B30E-42A6-B050-BD7E56D5AC38Q40548893-FEE1CAC6-E58D-4525-B891-F9111F8AB2FF
P2860
description
2005 nî lūn-bûn
@nan
2005 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
GB virus C replicates in primary T and B lymphocytes.
@ast
GB virus C replicates in primary T and B lymphocytes.
@en
type
label
GB virus C replicates in primary T and B lymphocytes.
@ast
GB virus C replicates in primary T and B lymphocytes.
@en
prefLabel
GB virus C replicates in primary T and B lymphocytes.
@ast
GB virus C replicates in primary T and B lymphocytes.
@en
P356
P1476
GB virus C replicates in primary T and B lymphocytes.
@en
P2093
Dino Varmaz
Sarah L George
P304
P356
10.1086/499435
P407
P577
2005-12-28T00:00:00Z